Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

830
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
830
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

277
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
277
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

30
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
30
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

33
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
33
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

578
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
578
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

290
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
290

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guild-Level Microbiome Signature Associated with COVID-19 Severity and Prognosis.

mBio·2023
Same author

Microbiota-derived acetate enhances host antiviral response via NLRP3.

Nature communications·2023
Same author

Gold nanoplatform for near-infrared light-activated radio-photothermal gas therapy in breast cancer.

Frontiers in bioengineering and biotechnology·2023
Same author

Effect of <i>Parthenium hysterophorus</i> L. Invasion on Soil Microbial Communities in the Yellow River Delta, China.

Microorganisms·2023
Same author

Microbiome Features Differentiating Unsupervised-Stratification-Based Clusters of Patients with Abnormal Glycometabolism.

mBio·2023
Same author

In vitro and Intracellular Antibacterial Activity of Sudapyridine (WX-081) Against Tuberculosis.

Infection and drug resistance·2023

Related Experiment Video

Updated: Feb 22, 2026

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills
06:52

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills

Published on: September 17, 2019

6.8K

Bayesian hierarchical model for analyzing multiresponse longitudinal pharmacokinetic data.

Liping Zhao1, Zhiming Xia1

  • 1Department of Mathematics, Northwest University, Xi'an, 710127, China.

Statistics in Medicine
|September 30, 2017
PubMed
Summary

This study introduces a Bayesian hierarchical model for analyzing complex Traditional Chinese Medicine (TCM) data. The model accurately calculates correlations between different ingredients, overcoming statistical challenges in TCM research.

Keywords:
MCMC algorithmhierarchical modelpharmacokinetictraditional Chinese medicine

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Related Experiment Videos

Last Updated: Feb 22, 2026

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills
06:52

Using Cholesky Decomposition to Explore Individual Differences in Longitudinal Relations between Reading Skills

Published on: September 17, 2019

6.8K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.8K

Area of Science:

  • Pharmacokinetics
  • Statistical Modeling
  • Traditional Chinese Medicine

Background:

  • Traditional Chinese Medicine (TCM) involves complex mixtures with numerous ingredients.
  • Analyzing multivariate pharmacokinetic data from TCM presents statistical challenges due to inter-ingredient associations and multiple time points.

Purpose of the Study:

  • To develop a robust statistical model for analyzing multivariate response pharmacokinetic data in TCM.
  • To address the high dimensionality and parameter estimation difficulties inherent in TCM data analysis.

Main Methods:

  • A 3-stage Bayesian hierarchical model was constructed.
  • Hybrid Markov Chain Monte Carlo (MCMC) algorithms were employed for posterior Bayesian estimation.
  • The model was validated using both simulation studies and real-world TCM data.

Main Results:

  • The proposed Bayesian hierarchical model effectively analyzes complex TCM pharmacokinetic data.
  • Hybrid MCMC algorithms provided accurate parameter estimations.
  • The model demonstrated high accuracy in calculating correlations among different TCM ingredients.

Conclusions:

  • The developed 3-stage Bayesian hierarchical model and MCMC algorithms offer a reliable approach for TCM data analysis.
  • This methodology enhances the accurate assessment of ingredient interactions in Traditional Chinese Medicine.